Evidence map›Paper›PMID 40136428›Full record

ArticleCurrent issues in molecular biology2025

Muazzez Derya-Andeden, Pinar Altin-Celik, Enver Ersoy Andeden, Hamiyet Donmez-Altuntas

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muazzez Derya-AndedenDepartment of Medical Biology, Faculty of Medicine, Erciyes University, 38030 Kayseri, Türkiye.ORCID 0000-0003-4390-5769
Pinar Altin-CelikDepartment of Medical Biology, Faculty of Medicine, Erciyes University, 38030 Kayseri, Türkiye.ORCID 0000-0001-8429-009X
Enver Ersoy AndedenDepartment of Molecular Biology and Genetics, Faculty of Art and Science, Hacı Bektaş Veli University, 50300 Nevşehir, Türkiye.ORCID 0000-0001-5774-8990
Hamiyet Donmez-AltuntasDepartment of Medical Biology, Faculty of Medicine, Erciyes University, 38030 Kayseri, Türkiye.ORCID 0000-0001-6473-5813

Funding

Health Institutes of Türkiye (TUSEB) 16824
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, and its prevalence is expected to double in the next 30 years. Currently, no effective treatment exists for Parkinson's disease. Thus, the research has focused on discovering new natural compounds with strong neuroprotective potential. This study aimed to investigate the effects of the methanol extract of

Indexed as

6-OHDAmicroalgaemitochondrial damageoxidative stressParkinson’s diseaseSH-SY5Y

Identifiers

PMID40136428
PMCPMC11941442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.